Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04841330 · ClinicalTrials.gov registry record
Prospective Healthy Volunteer Study of the Securis™ Stabilization Device
A clinical trial of Peripheral Intavenous Catheter Stabilization, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- 104
- Enrollment target
- 1
- Study location
NCT04841330: Completed study of Peripheral Intavenous Catheter Stabilization, sponsored by Becton, Dickinson and Company.
NCT04841330 is a study of Peripheral Intavenous Catheter Stabilization that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 104 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04841330, a study of Peripheral Intavenous Catheter Stabilization, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to assess the performance of the Securis™ Stabilization Device in simulated clinical use.
Primary Outcome
Device securement failure is defined as any of the following: * Loose dressing * Soiled under dressing * Complete failure (complete removal) * Dislodgement of device or catheter
Conditions Studied
Interventions
- DEVICE Securis™ Stabilization Device
Study Locations (1)
New Jersey
- TKL Research, Inc - Fair Lawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2021-06-09 |
| Est. Completion | 2021-07-20 |
What the finished NCT04841330 record still lists
NCT04841330 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Peripheral Intavenous Catheter Stabilization appearing as the primary indexed condition, and to 1 intervention - of which Securis™ Stabilization Device is the first listed.
NCT04841330 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04841330 about?
NCT04841330 is a clinical study titled "Prospective Healthy Volunteer Study of the Securis™ Stabilization Device". This study is being conducted to assess the performance of the Securis™ Stabilization Device in simulated clinical use.
What is the current status of trial NCT04841330?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2021-06-09. Estimated completion is 2021-07-20.
What conditions does trial NCT04841330 study?
This clinical trial studies the following conditions: Peripheral Intavenous Catheter Stabilization.
What interventions are being tested in trial NCT04841330?
The interventions under investigation include: Securis™ Stabilization Device (DEVICE).
Who is sponsoring clinical trial NCT04841330?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04841330 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI